Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), has appointed Hanna Lesch as chief technology officer. Lesch’s extensive experience in cell and gene therapies will further extend Exothera’s capabilities in designing high-quality, cost-effective viral vector processes tailored to the requirements of its customers’ particular molecules. Lesch has dedicated her career to gene therapy and has held several director positions including leading res...